Elevra Lithium Clears Path for Major NAL Expansion

Elevra Lithium Limited has announced the results of its Pre-Feasibility Study (PFS) for the staged brownfield expansion of its North American Lithium (NAL) operation in Québec. The study confirms that the expansion could significantly increase spodumene concentrate production, lower unit operating costs, and create substantial additional value from existing infrastructure and operating assets.

The NAL Expansion will be implemented in three stages. Stage 1 is expected to raise processing plant throughput to the currently permitted 4,500 tonnes per day (tpd) from mid-2027. Stage 2 will increase milling capacity to 6,500 tpd from mid-2028, while Stage 3 will establish a permanent crushing solution aligned with the higher milling capacity by mid-2029.

Following the expansion and ramp-up, average annual spodumene concentrate production is projected at 373,000 tonnes per annum (ktpa), based on nominal 5.4% Li2O concentrate. This represents nearly twice the 199 ktpa average production expected under the base case and is approximately 10% higher than the 338 ktpa estimate included in the company’s May 2026 study. The additional output is expected to benefit from improved mill feed grades supported by ore-sorting technology.

The expansion is also expected to improve cost efficiency. Life-of-mine (LOM) C1 operating costs are estimated at C$876/t of concentrate, compared with C$1,048/t under the base case. Post-expansion C1 costs are projected to decline further to approximately C$851/t. LOM all-in sustaining costs (AISC) are estimated at C$954/t, falling to C$918/t after expansion.

Elevra estimates initial capital expenditure at C$366 million, including C$73 million in contingency. Stage 1 requires approximately C$92 million, Stage 2 C$101 million, and Stage 3 C$173 million. The company said the expansion is fully funded through its strategic financing package announced in May 2026.

The project’s economics are particularly strong. The expansion-only post-tax NPV at an 8% discount rate is estimated at C$943 million, with a post-tax internal rate of return of 49.9% and a payback period of 34 months.

The expansion is supported entirely by existing Proven and Probable Ore Reserves totaling 47.2 million tonnes at 1.12% Li2O. No Inferred Mineral Resources have been included in the economic analysis or production target.

Overall, the PFS strengthens Elevra’s plans to expand NAL through a staged development strategy, enabling additional production from mid-2027 while seeking to capture operating efficiencies and manage capital deployment.

Impact on Product and Chemical Commodity Prices

The announcement is positive for spodumene concentrate and lithium supply, as NAL’s expansion could raise average annual production to 373 ktpa, adding significant material to the market from 2027 onward. Higher spodumene availability may increase feedstock supply for lithium chemical producers and potentially ease raw-material tightness. However, the effect on lithium carbonate and lithium hydroxide prices is likely to be limited initially because the additional capacity will ramp up gradually through 2029. If global lithium demand remains strong, the added supply could be absorbed without substantial price pressure. For ChemAnalyst-tracked lithium commodities, the development is therefore moderately bearish for prices over the medium term, particularly if other producers also expand output.